Korean Journal of Biological Psychiatry (생물정신의학)

The Korean Society of Biological Psychiatry (대한생물정신의학회)
권호 표지

Characteristics of Subsyndromal Anxiety Disorder and Its Clinical Importance

Subsyndromal Anxiety Disorder의 특징과 임상적 중요성

  • Kang, Nam-In (Department of Psychiatry, Chonbuk National University Hospital & Research Institute of Clinical Medicine) ;
  • Yang, Jong-Chul (Department of Psychiatry, Chonbuk National University Hospital & Research Institute of Clinical Medicine)
  • 강남인 (전북대학교병원 정신과) ;
  • 양종철 (전북대학교병원 정신과)
  • Received : 2011.08.10
  • Accepted : 2011.09.30
  • Published : 2011.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

Subsyndromal anxiety disorder indicates mental states of having anxiety symptoms not fulfilling criteria for anxiety disorders. Despite of the lack of previous objective findings of the subsyndromal anxiety disorder, its clinical importance has increased. It can cause many kinds of clinical anxiety symptoms and functional disabilities. But the early intervention and early treatment make it possible not only to attenuate the anxiety symptoms and functional disabilities but also to prevent disease progression to a full syndromal anxiety disorder. In this article, we will review the previous studies about the subsyndromal anxiety disorder and discuss its clinical characteristics and importance.

Keywords

References

  1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:593-602. https://doi.org/10.1001/archpsyc.62.6.593
  2. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:617-627. https://doi.org/10.1001/archpsyc.62.6.617
  3. Angst J, Merikangas KR, Preisig M. Subthreshold syndromes of depression and anxiety in the community. J Clin Psychiatry 1997; 58 Suppl 8:6-10.
  4. Norton J, de Roquefeuil G, David M, Boulenger JP, Ritchie K, Mann A. [Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription]. Encephale 2009;35:560-569. https://doi.org/10.1016/j.encep.2008.06.018
  5. Cho MJ, Chang SM, Hahm BJ, Chung IW, Bae A, Lee YM, et al. Lifetime risk and age of onset distributions of psychiatric disorders: analysis of national sample survey in South Korea. Soc Psychiatry Psychiatr Epidemiol 2011. [Epub ahead of print]
  6. Comino EJ, Harris E, Silove D, Manicavasagar V, Harris MF. Prevalence, detection and management of anxiety and depressive symptoms in unemployed patients attending general practitioners. Aust N Z J Psychiatry 2000;34:107-113. https://doi.org/10.1046/j.1440-1614.2000.00645.x
  7. Mendlowicz MV, Stein MB. Quality of life in individuals with anxiety disorders. Am J Psychiatry 2000;157:669-682. https://doi.org/10.1176/appi.ajp.157.5.669
  8. Regier DA, Burke JD Jr, Manderscheid RW, Burns BJ. The chronically mentally ill in primary care. Psychol Med 1985;15:265-273. https://doi.org/10.1017/S0033291700023540
  9. Weiller E, Bisserbe JC, Maier W, Lecrubier Y. Prevalence and recognition of anxiety syndromes in five European primary care settings. A report from the WHO study on Psychological Problems in General Health Care. Br J Psychiatry Suppl 1998:18-23.
  10. Greenberg PE, Sisitsky T, Kessler RC, Finkelstein SN, Berndt ER, Davidson JR, et al. The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry 1999;60:427-435. https://doi.org/10.4088/JCP.v60n0702
  11. Mall AK, Mehl A, Kiko S, Kleindienst N, Salize HJ, Hermann C, et al. Evaluation of a DVD-based self-help program in highly socially anxious individuals--pilot study. Behav Ther 2011;42:439-448. https://doi.org/10.1016/j.beth.2010.11.007
  12. Cattell RB. Psychological definition and measurement of anxiety. J Neuropsychiatr 1964;5:396-402.
  13. Lazarus RS. Emotion and adaptation. New York: Oxford University Press;1991.
  14. Fagerberg E. Somatic symptoms in anxiety. Acta Soc Med Ups 1951;56:139-148.
  15. Grenier S, Preville M, Boyer R, O'Connor K, Béland SG, Potvin O, et al. The impact of DSM-IV symptom and clinical significance criteria on the prevalence estimates of subthreshold and threshold anxiety in the older adult population. Am J Geriatr Psychiatry 2011;19: 316-326. https://doi.org/10.1097/JGP.0b013e3181ff416c
  16. Carter RM, Wittchen HU, Pfister H, Kessler RC. One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample. Depress Anxiety 2001; 13:78-88. https://doi.org/10.1002/da.1020
  17. Heun R, Papassotiropoulos A, Ptok U. Subthreshold depressive and anxiety disorders in the elderly. Eur Psychiatry 2000;15:173-182. https://doi.org/10.1016/S0924-9338(00)00228-5
  18. Klein DF. Mixed anxiety depression. For and against. Encephale 1993;19 Spec No 3:493-495.
  19. Aronson TA. Atypical anxiety disorder: a descriptive study. Compr Psychiatry 1990;31:152-161. https://doi.org/10.1016/0010-440X(90)90019-O
  20. Kogan JN, Edelstein BA, McKee DR. Assessment of anxiety in older adults: current status. J Anxiety Disord 2000;14:109-132. https://doi.org/10.1016/S0887-6185(99)00044-4
  21. Karsten J, Nolen WA, Penninx BW, Hartman CA. Subthreshold anxiety better defined by symptom self-report than by diagnostic interview. J Affect Disord 2011;129:236-243. https://doi.org/10.1016/j.jad.2010.09.006
  22. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988;56:893-897.
  23. Creamer M, Foran J, Bell R. The Beck Anxiety Inventory in a nonclinical sample. Behav Res Ther 1995;33:477-485. https://doi.org/10.1016/0005-7967(94)00082-U
  24. Karsten J, Hartman CA, Smit JH, Zitman FG, Beekman AT, Cuijpers P, et al. Psychiatric history and subthreshold symptoms as predictors of the occurrence of depressive or anxiety disorder within 2 years. Br J Psychiatry 2011;198:206-212. https://doi.org/10.1192/bjp.bp.110.080572
  25. Taylor AJ, Aghanwa HS, Walkey FH. Fiji norms and a cross-cultural clinical validation of the General Health Questionnaire (GHQ 20). Pac Health Dialog 2003;10:62-65.
  26. Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale--preliminary report. Psychopharmacol Bull 1973;9:13-28.
  27. Roy-Byrne P, Katon W, Broadhead WE, Lepine JP, Richards J, Brantley PJ, et al. Subsyndromal ("mixed") anxiety--depression in primary care. J Gen Intern Med 1994;9:507-512. https://doi.org/10.1007/BF02599221
  28. Sansone RA, Hendricks CM, Gaither GA, Reddington A. Prevalence of anxiety symptoms among a sample of outpatients in an internal medicine clinic: a pilot study. Depress Anxiety 2004;19:133-136. https://doi.org/10.1002/da.10143
  29. Leon AC, Olfson M, Broadhead WE, Barrett JE, Blacklow RS, Keller MB, et al. Prevalence of mental disorders in primary care. Implications for screening. Arch Fam Med 1995;4:857-861. https://doi.org/10.1001/archfami.4.10.857
  30. Marcus SC, Olfson M, Pincus HA, Shear MK, Zarin DA. Self-reported anxiety, general medical conditions, and disability bed days. Am J Psychiatry 1997;154:1766-1768.
  31. Rabe-Jabłonska J. [Panic attacks and panic disorder. Diagnostic criteria, prevalence, etiopathogenesis, clinical presentation and treatment]. Psychiatr Pol 1993;27:165-179.
  32. Fleet RP, Dupuis G, Marchand A, Burelle D, Arsenault A, Beitman BD. Panic disorder in emergency department chest pain patients: prevalence, comorbidity, suicidal ideation, and physician recognition. Am J Med 1996;101:371-380. https://doi.org/10.1016/S0002-9343(96)00224-0
  33. Morris A, Baker B, Devins GM, Shapiro CM. Prevalence of panic disorder in cardiac outpatients. Can J Psychiatry 1997;42:185-190.
  34. Batelaan N, De Graaf R, Van Balkom A, Vollebergh W, Beekman A. Thresholds for health and thresholds for illness: panic disorder versus subthreshold panic disorder. Psychol Med 2007;37:247-256. https://doi.org/10.1017/S0033291706009007
  35. Bystritsky A, Kerwin L, Niv N, Natoli JL, Abrahami N, Klap R, et al. Clinical and subthreshold panic disorder. Depress Anxiety 2010; 27:381-389. https://doi.org/10.1002/da.20622
  36. Batelaan NM, de Graaf R, Spijker J, Smit JH, van Balkom AJ, Vollebergh WA, et al. The course of panic attacks in individuals with panic disorder and subthreshold panic disorder: a population-based study. J Affect Disord 2010;121:30-38. https://doi.org/10.1016/j.jad.2009.05.003
  37. Skapinakis P, Lewis G, Davies S, Brugha T, Prince M, Singleton N. Panic disorder and subthreshold panic in the UK general population: epidemiology, comorbidity and functional limitation. Eur Psychiatry 2011;26:354-362.
  38. Meulenbeek P, Willemse G, Smit F, van Balkom A, Spinhoven P, Cuijpers P. Early intervention in panic: randomized controlled trial and cost-effectiveness analysis. Trials 2008;9:67. https://doi.org/10.1186/1745-6215-9-67
  39. Stein MB, Kean YM. Disability and quality of life in social phobia: epidemiologic findings. Am J Psychiatry 2000;157:1606-1613. https://doi.org/10.1176/appi.ajp.157.10.1606
  40. Fehm L, Beesdo K, Jacobi F, Fiedler A. Social anxiety disorder above and below the diagnostic threshold: prevalence, comorbidity and impairment in the general population. Soc Psychiatry Psychiatr Epidemiol 2008;43:257-265. https://doi.org/10.1007/s00127-007-0299-4
  41. Knappe S, Beesdo K, Fehm L, Lieb R, Wittchen HU. Associations of familial risk factors with social fears and social phobia: evidence for the continuum hypothesis in social anxiety disorder? J Neural Transm 2009;116:639-648. https://doi.org/10.1007/s00702-008-0118-4
  42. Aune T, Stiles TC. Universal-based prevention of syndromal and subsyndromal social anxiety: A randomized controlled study. J Consult Clin Psychol 2009;77:867-879.
  43. Pollack MH. Refractory generalized anxiety disorder. J Clin Psychiatry 2009;70 Suppl 2:32-38. https://doi.org/10.4088/JCP.s.7002.06
  44. Barbee JG, Billings CK, Bologna NB, Townsend MH. A follow-up study of DSM-III-R generalized anxiety disorder with syndromal and subsyndromal major depression. J Affect Disord 2003;73:229-236. https://doi.org/10.1016/S0165-0327(00)00168-3
  45. Diefenbach GJ, Hopko DR, Feigon S, Stanley MA, Novy DM, Beck JG, et al. 'Minor GAD': characteristics of subsyndromal GAD in older adults. Behav Res Ther 2003;41:481-487. https://doi.org/10.1016/S0005-7967(02)00130-4
  46. Husband SD, Platt JJ. Criteria for the diagnosis of PTSD. Am J Psychiatry 1987;144:388.
  47. Shelby RA, Golden-Kreutz DM, Andersen BL. PTSD diagnoses, subsyndromal symptoms, and comorbidities contribute to impairments for breast cancer survivors. J Trauma Stress 2008;21:165-172. https://doi.org/10.1002/jts.20316
  48. Jakupcak M, Hoerster KD, Varra A, Vannoy S, Felker B, Hunt S. Hopelessness and suicidal ideation in Iraq and Afghanistan War Veterans reporting subthreshold and threshold posttraumatic stress disorder. J Nerv Ment Dis 2011;199:272-275. https://doi.org/10.1097/NMD.0b013e3182124604
  49. Cukor J, Wyka K, Jayasinghe N, Difede J. The nature and course of subthreshold PTSD. J Anxiety Disord 2010;24:918-923. https://doi.org/10.1016/j.janxdis.2010.06.017
  50. Kenardy J, Cobham V, Nixon RD, McDermott B, March S. Protocol for a randomised controlled trial of risk screening and early intervention comparing child- and family-focused cognitive-behavioural therapy for PTSD in children following accidental injury. BMC Psychiatry 2010;10:92. https://doi.org/10.1186/1471-244X-10-92
  51. Adam Y, Meinlschmidt G, Gloster AT, Lieb R. Obsessive-compulsive disorder in the community: 12-month prevalence, comorbidity and impairment. Soc Psychiatry Psychiatr Epidemiol;2011.
  52. Zohar AH. The epidemiology of obsessive-compulsive disorder in children and adolescents. Child Adolesc Psychiatr Clin N Am 1999;8: 445-460.
  53. Maina G, Albert U, Bogetto F, Ravizza L. Onset of obsessive-compulsive disorder: premorbid conditions and prodromal phase. CNS Spectr 2000;5:31-43.
  54. Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry 2010;15:53-63. https://doi.org/10.1038/mp.2008.94
  55. Anxiety and physical illness. Understanding and treating anxiety can often improve the outcome of chronic disease. Harv Womens Health Watch 2008;15:6-7.
  56. Murphy JM, Sobol AM, Olivier DC, Monson RR, Leighton AH, Pratt LA. Prodromes of depression and anxiety. The Stirling County study. Br J Psychiatry 1989;155:490-495. https://doi.org/10.1192/bjp.155.4.490
  57. Altamura AC, Montresor C, Salvadori D, Mundo E. Does comorbid subthreshold anxiety affect clinical presentation and treatment response in depression? A preliminary 12-month naturalistic study. Int J Neuropsychopharmacol 2004;7:481-487. https://doi.org/10.1017/S1461145704004626
  58. Papakostas GI, Petersen T, Hughes ME, Nierenberg AA, Alpert JE, Fava M. Anxiety and somatic symptoms as predictors of treatmentrelated adverse events in major depressive disorder. Psychiatry Res 2004;126:287-290. https://doi.org/10.1016/j.psychres.2004.02.007
  59. Kirmizioglu Y, Dogan O, Kugu N, Akyuz G. Prevalence of anxiety disorders among elderly people. Int J Geriatr Psychiatry 2009;24: 1026-1033. https://doi.org/10.1002/gps.2215
  60. Nordhus IH, Pallesen S. Psychological treatment of late-life anxiety: an empirical review. J Consult Clin Psychol 2003;71:643-651.
  61. Sartorius N, Ustün TB, Lecrubier Y, Wittchen HU. Depression comorbid with anxiety: results from the WHO study on psychological disorders in primary health care. Br J Psychiatry Suppl 1996:38-43.
  62. Cohen CI, Magai C, Yaffee R, Walcott-Brown L. The prevalence of anxiety and associated factors in a multiracial sample of older adults. Psychiatr Serv 2006;57:1719-1725. https://doi.org/10.1176/appi.ps.57.12.1719
  63. Burcusa SL, Iacono WG. Risk for recurrence in depression. Clin Psychol Rev 2007;27:959-985. https://doi.org/10.1016/j.cpr.2007.02.005
  64. Miller LD, Laye-Gindhu A, Bennett JL, Liu Y, Gold S, March JS, et al. An effectiveness study of a culturally enriched school-based CBT anxiety prevention program. J Clin Child Adolesc Psychol 2011;40:618-629 doi: 10.1080/15374416.2011.581619.
  65. Lau EX, Rapee RM. Prevention of anxiety disorders. Curr Psychiatry Rep 2011;13:258-266. https://doi.org/10.1007/s11920-011-0199-x
  66. Anderson KC, Insel TR. The promise of extinction research for the prevention and treatment of anxiety disorders. Biol Psychiatry 2006; 60:319-321. https://doi.org/10.1016/j.biopsych.2006.06.022
  67. Bienvenu OJ, Ginsburg GS. Prevention of anxiety disorders. Int Rev Psychiatry 2007;19:647-654. https://doi.org/10.1080/09540260701797837
  68. Balle M, Tortella-Feliu M. Efficacy of a brief school-based program for selective prevention of childhood anxiety. Anxiety Stress Coping 2010;23:71-85. https://doi.org/10.1080/10615800802590652
  69. Wittchen HU, Zhao S, Kessler RC, Eaton WW. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:355-364. https://doi.org/10.1001/archpsyc.1994.03950050015002
  70. Rinfrette ES. Treatment of anxiety, depression, and alcohol disorders in the elderly: social work collaboration in primary care. J Evid Based Soc Work 2009;6:79-91. https://doi.org/10.1080/15433710802633569
  71. Tambs K, Czajkowsky N, Røysamb E, Neale MC, Reichborn-Kjennerud T, Aggen SH, et al. Structure of genetic and environmental risk factors for dimensional representations of DSM-IV anxiety disorders. Br J Psychiatry 2009;195:301-307. https://doi.org/10.1192/bjp.bp.108.059485
  72. Ehli EA, Hu Y, Lengyel-Nelson T, Hudziak JJ, Davies GE. Identification and functional characterization of three novel alleles for the serotonin transporter-linked polymorphic region. Mol Psychiatry 2011. [Epub ahead of print]
  73. Hohoff C, Mullings EL, Heatherley SV, Freitag CM, Neumann LC, Domschke K, et al. Adenosine A (2A) receptor gene: evidence for association of risk variants with panic disorder and anxious personality. J Psychiatr Res 2010;44:930-937. https://doi.org/10.1016/j.jpsychires.2010.02.006
  74. Unschuld PG, Ising M, Specht M, Erhardt A, Ripke S, Heck A, et al. Polymorphisms in the GAD2 gene-region are associated with susceptibility for unipolar depression and with a risk factor for anxiety disorders. Am J Med Genet B Neuropsychiatr Genet 2009;150B: 1100-1109. https://doi.org/10.1002/ajmg.b.30938
  75. Pham X, Sun C, Chen X, van den Oord EJ, Neale MC, Kendler KS, et al. Association study between GABA receptor genes and anxiety spectrum disorders. Depress Anxiety 2009;26:998-1003. https://doi.org/10.1002/da.20628
  76. Montag C, Reuter M, Newport B, Elger C, Weber B. The BDNF Val- 66Met polymorphism affects amygdala activity in response to emotional stimuli: evidence from a genetic imaging study. Neuroimage 2008;42:1554-1559. https://doi.org/10.1016/j.neuroimage.2008.06.008
  77. Smoller JW, Yamaki LH, Fagerness JA, Biederman J, Racette S, Laird NM, et al. The corticotropin-releasing hormone gene and behavioral inhibition in children at risk for panic disorder. Biol Psychiatry 2005;57:1485-1492. https://doi.org/10.1016/j.biopsych.2005.02.018